Cardinal Health report highlights cost savings and provider confidence in biosimilars

New analysis shows biosimilars are projected to strengthen cost savings and provider confidence across the healthcare ecosystem, with oncology leading in adoption and accessibility gains. DUBLIN, Ohio, Feb. 24, 2026 /PRNewswire/ -- Cardinal Health (NYSE: CAH) today released its 2026 Biosimilars Report: Driving access and patient outcomes in physician practices, which highlights the substantial savings biosimilars have delivered to the U.S. healthcare system and the strong confidence providers have in these treatments.

PRNewsWire • 13 hours ago

Q4 Earnings: These Buy-Rated Stocks Crushed Expectations

The 2025 Q4 earnings cycle keeps rolling along, with overall growth remaining strong. Specifically, these companies knocked it out of the park, with both also sporting a favorable Zacks Rank.

Zacks Investment Research • Feb 19, 2026

Wall Street Analysts See Cardinal (CAH) as a Buy: Should You Invest?

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?

Zacks Investment Research • Feb 17, 2026

BOOT & 3 Other Stocks With Strong Interest Coverage to Buy Now

BOOT joins EAT, TPR and CAH on a screen for strong interest coverage, solid volume and growth, spotlighting four stocks that made the cut.

Zacks Investment Research • Feb 17, 2026

Are Investors Undervaluing Cardinal Health (CAH) Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks Investment Research • Feb 13, 2026

Best Momentum Stock to Buy for February 13th

LTM, ING and CAH made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on February 13, 2026.

Zacks Investment Research • Feb 13, 2026

Cardinal Health Board of Directors Approves Quarterly Dividend

DUBLIN, Ohio, Feb. 12, 2026 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today that its Board of Directors approved its quarterly dividend of $0.5107 per share, out of the Company's capital surplus. The dividend will be payable on April 15, 2026 to shareholders of record at the close of business on April 1, 2026.

PRNewsWire • Feb 12, 2026

Why Cardinal Health (CAH) is a Top Value Stock for the Long-Term

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks Investment Research • Feb 12, 2026

20 stocks of companies that delivered a double dose of growth this earnings season

Companies in the S&P 500 achieving double-digit sales growth while improving profit margins include Palantir, Micron, Boeing and Alphabet.

Market Watch • Feb 11, 2026

Earnings Winners: 2 Buy Rated Stocks Raising Guidance

The 2025 Q4 earnings season continues to be one of positivity, with several companies, including these two that sport buy ratings, knocking it out of the park and raising their outlooks.

Zacks Investment Research • Feb 9, 2026